J&J's Mylanta Sees $20M, PM SKU

Bittar, Christine
May 2000
Brandweek;05/29/2000, Vol. 41 Issue 22, p6
Trade Publication
Reports on the advertising campaign for Johnson & Johnson/Merck & Company's Mylanta Night Time Strength liquid antacid. Advertising cost; Reasons for the decline in the sales of the antacid for months ending March 26, 2000; Target market for the antacid.


Related Articles

  • J&J Hopes Vanilla Licks Taste Issue. Bittar, Christine // Brandweek;10/04/99, Vol. 40 Issue 37, p4 

    Reports that Johnson and Johnson/Merck (J&J) is adding vanilla to its antacid brand, Mylanta Supreme. Suggestion of J&J to retailers on how to sell the brand; Complaint of the consumers against the brand; Decline of Mylanta's sales for fiscal year ended April 25, 1999.

  • Major push for Pepcid.  // Drug Topics;6/12/95, Vol. 139 Issue 11, p7 

    Reports on Johnson & Johnson/Merck's spending of about 100$ million to advertise and promote Pepcid.

  • J&J plots supreme command. Bittar, Christine // Brandweek;11/16/98, Vol. 39 Issue 43, p1 

    Reports on Johnson & Johnson/Merck's launch of an advertising and sampling campaign designed to reinvigorate its beleaguered Mylanta brand. Plan to launch the Fast Acting Mylanta Supreme across the first half of 1999; Major competitors of Mylanta in the over-the-counter segment; Publication of...

  • J&J/Merck's Pepcid races to OTC. Wilke, Michael // Advertising Age;5/29/1995, Vol. 66 Issue 22, p12 

    Reports on the launching of Johnson & Johnson/Merck's over-the-counter (OTC) antacid, Pepcid AC in the United States. Implications for the stomach remedies market; OTC approval from the Food & Drug Administration; Mechanism of action; Similar products waiting in line; Plans for marketing support...

  • Rhino Is Complete For Pepcid.  // SHOOT;04/20/2001, Vol. 42 Issue 16, p19 

    Presents information on the production of television commercials for Johnson & Johnson Co. and Merck Consumer Pharmaceuticals Co.'s antacid brand, by Saatchi & Saatchi New York. Production company; Editorial; Post/visual effects; Audio post; Music/sound design; Theme of the commercial.

  • Mylanta Pumps $35M For Chewy, Extra Calcium. Bittar, Christine // Brandweek;11/22/99, Vol. 40 Issue 44, p5 

    Announces the launching of an antacid lineup from Johnson and Johnson/Merck. Budget alloted for the product launch; Selling points of the company's rival product which it is trying to outdo; Description of the product features.

  • OTC Thought Letters. Breitstein, Joanna // Pharmaceutical Executive;Apr2003, Vol. 23 Issue 4, p71 

    Reports on Johnson & Johnson-Merck Consumer Pharmaceuticals' co-venture for the launching of a product message campaign in support for the heartburn drug Pepcid Complete. Emphasis on the consultative rapport between pharmacists and patients; Inclusion of a consumer education kit; Marketing...

  • New J&J brand targets digestion problems.  // Marketing Week;7/2/1998, Vol. 21 Issue 18, p8 

    Reports on the plans of consumer pharmaceutical company Johnson and Johnson (J&J) Merck Sharp Dohme (MSD), to create a drug category to treat digestion problems with the launch of Domperidone. Statement issued by J&J on the creation of the category; Comments by the company on Domperidone;...

  • Getting Pepcid In Better Shape. Bittar, Christine // Brandweek;10/04/99, Vol. 40 Issue 37, p1 

    Focuses on the marketing strategy of Johnson and Johnson/Merck (J&J) for its antacid brand, Pepcid Gelcaps. Argument of J&J advertising campaign for Gelcaps; Decline of Pepcid sales for the first four months of 1999; Investment plan for the product.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics